513 related articles for article (PubMed ID: 2842653)
21. Yangambin: a new naturally-occurring platelet-activating factor receptor antagonist: binding and in vitro functional studies.
Castro-Faria-Neto HC; Bozza PT; Cruz HN; Silva CL; Violante FA; Barbosa-Filho JM; Thomas G; Martins MA; Tibiriçá EV; Noel F
Planta Med; 1995 Apr; 61(2):101-5. PubMed ID: 7753913
[TBL] [Abstract][Full Text] [Related]
22. Further characterization of PAF receptor and novel antagonists.
Shen TY; Hussaini I
Int J Tissue React; 1990; 12(2):63-9. PubMed ID: 2170286
[TBL] [Abstract][Full Text] [Related]
23. [Characterization of platelet-activating factor (PAF)-receptors in neutrophilic and eosinophilic granulocytes].
Ukena D; Dent G; Chanez P; Barnes PJ; Sybrecht GW
Pneumologie; 1990 Feb; 44 Suppl 1():531-2. PubMed ID: 2164200
[TBL] [Abstract][Full Text] [Related]
24. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies.
Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C
J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624
[TBL] [Abstract][Full Text] [Related]
25. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
[TBL] [Abstract][Full Text] [Related]
26. Binding of [3H]SR 27417, a novel platelet-activating factor (PAF) receptor antagonist, to rabbit and human platelets and polymorphonuclear leukocytes.
Herbert JM; Laplace MC; Maffrand JP
Biochem Pharmacol; 1993 Jan; 45(1):51-8. PubMed ID: 8381007
[TBL] [Abstract][Full Text] [Related]
27. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets.
Mais DE; Kochel PJ; Saussy DL; Halushka PV
Mol Pharmacol; 1985 Aug; 28(2):163-9. PubMed ID: 2991736
[TBL] [Abstract][Full Text] [Related]
28. Identification of functional platelet-activating factor receptors in Raji lymphoblasts.
Travers JB; Li Q; Kniss DA; Fertel RH
J Immunol; 1989 Dec; 143(11):3708-13. PubMed ID: 2555416
[TBL] [Abstract][Full Text] [Related]
29. Identification of platelet-activating factor receptors in P388D1 murine macrophages.
Valone FH
J Immunol; 1988 Apr; 140(7):2389-94. PubMed ID: 2832476
[TBL] [Abstract][Full Text] [Related]
30. Pharmacologic characterization of the rabbit neutrophil receptor for platelet-activating factor.
Paulson SK; Wolf JL; Novotney-Barry A; Cox CP
Proc Soc Exp Biol Med; 1990 Nov; 195(2):247-54. PubMed ID: 2172997
[TBL] [Abstract][Full Text] [Related]
31. Wheat germ agglutinin potentiates specific binding of platelet-activating factor to human platelet membranes and induces platelet-activating factor synthesis in intact platelets.
Hwang SB; Wang S
Mol Pharmacol; 1991 Jun; 39(6):788-97. PubMed ID: 2051992
[TBL] [Abstract][Full Text] [Related]
32. Octylonium bromide interacts competitively with the PAF receptor.
Barone D; Maggi CA; Baroldi P; Giachetti A; Meli A
Drugs Exp Clin Res; 1989; 15(8):363-7. PubMed ID: 2557193
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models.
Nagaoka J; Harada K; Kimura A; Kobayashi S; Murakami M; Yoshimura T; Yamada K; Asano O; Katayama K; Yamatsu I
Arzneimittelforschung; 1991 Jul; 41(7):719-24. PubMed ID: 1663352
[TBL] [Abstract][Full Text] [Related]
34. Characterization of platelet-activating factor binding sites on uterine membranes from pregnant rabbits.
Kudolo GB; Harper MJ
Biol Reprod; 1989 Oct; 41(4):587-603. PubMed ID: 2559778
[TBL] [Abstract][Full Text] [Related]
35. Reversible or irreversible modification of [3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists.
Domingo MT; Piro F; Broquet C; Auclair E; Chabrier PE; Braquet P
Lipids; 1992 Aug; 27(8):582-6. PubMed ID: 1328798
[TBL] [Abstract][Full Text] [Related]
36. L-659,989: a useful probe in the detection of multiple conformational states of PAF receptors.
Hwang SB; Lam MH
Lipids; 1991 Dec; 26(12):1148-53. PubMed ID: 1668109
[TBL] [Abstract][Full Text] [Related]
37. Characterization of specific binding sites of 3H-labelled platelet-activating factor ([3H]PAF) and a new antagonist, [3H]SR 27417, on guinea-pig tracheal epithelial cells.
Herbert JM
Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):201-6. PubMed ID: 1318021
[TBL] [Abstract][Full Text] [Related]
38. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
Bastos da Silva M; Delaunois A; Gustin P; Godeau JM; Lekeux P
Vet Res; 2000; 31(2):267-72. PubMed ID: 10779205
[TBL] [Abstract][Full Text] [Related]
39. Binding of platelet-activating factor to oviductal membranes during early pregnancy in the rabbit.
Yang YQ; Kudolo GB; Harper MJ
J Lipid Mediat; 1992 Feb; 5(1):77-96. PubMed ID: 1391740
[TBL] [Abstract][Full Text] [Related]
40. Alpha 2-adrenergic receptors on canine platelet membranes characterized by [3H]-yohimbine binding.
O'Hara N; Yokota S; Kouchi Y; Ono H
Res Commun Chem Pathol Pharmacol; 1986 May; 52(2):179-94. PubMed ID: 3012728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]